How we’re taking
the next big step
From the Nano to the Macro, we’re developing next generation polymer technology. Our tech will power the manufacture of innovative medical products for years to come.
Nanoparticles & Microparticles
Fibrous Implants
Gels & Films
Surface Coatings
Injectable Implant
3D Printed Implants
tunable parameters, tunable results
Our polymers outperform old drug delivery systems.
| Tunable Parameters | ||||
| Variables | Biomedical Polymer Systems | |||
| Polymer (PCL, PLA) | Copolymers (PLGA) | Pendant Polymers | ||
| Polymer MW | ||||
| Monomer ratios | ||||
| Pendant functionalization | ||||
| Crosslinker chemistry | ||||
| Degree of crosslinking | ||||
| Tunable Results | ||||
| Loading | ||||
| Release | ||||
| Porosity | ||||
| Swelling | ||||
| Mechanical Properties | ||||
Through technology, we access major underserved market segments.
Global Injectable Drug Delivery = $404B in 2017, $1200B by 2026*
Pendant Bio’s technology accesses two major market segments:
in 2017
Total Injectables Market
by 20261
Surface Coatings Market
in 2017
by 20262
*Research and Markets, 2018; 1BCC Research, 2018; 2Statistics MRC and Wiseguys Reports, 2018
Intellectual property fuels growth.
PCT Filed: 1
Flexibility drives differentiation.
Pendant Bio is better at drug delivery because our affordable polymer platform is more versatile than old systems, and can more predictably solve today’s most difficult drug delivery challenges regardless of the active pharmaceutical ingredient.
Pendant Bio is better at coatings because we’ve combined a surface modification system with a drug delivery platform, which provides more flexibility to design the differentiated products required for success in today’s medical device arena.
| Company | Coatings | Drug Delivery | Stage |
| Pendant Bio | Preclinical | ||
| Evonik | Marketed | ||
| Harland Medical | Marketed | ||
| Innocore Pharmaceuticals | Preclinical | ||
| PolyActiva | Preclinical | ||
| DSM | Marketed | ||
| Auritec Pharmaceuticals | Preclinical | ||
| Surmodics | Marketed | ||
| Polymer Therapeutics | Preclinical |